Detailed Quote:IPIX INNOVATION PHARMACEUTICALS

New Post Public Reply Private Reply Replies (5) Message Board
4kids 4kids #66698
966
Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.20675Down -0.00625 (-2.934272 %) AS OF 3:59:53PM ET 10/16/2020

Price Performance (Last 52 Weeks)
10/15/2020 +105.80%


Volume 833,773
Volume (10 day Average) 1,454,836
Volume (90 day Average) 2,922,985


Market Capitalization $73.95M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.213Down -0.0019 (-0.884132 %) AS OF 3:59:28PM ET 10/15/2020

Price Performance (Last 52 Weeks)
10/14/2020 +99.91%


Volume 425,401
Volume (10 day Average) 1,479,057
Volume (90 day Average) 2,929,936


Market Capitalization $74.61M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2149Down -0.0051 (-2.318182 %) AS OF 3:59:42PM ET 10/14/2020

Price Performance (Last 52 Weeks)
10/13/2020 +124.49%


Volume 613,853
Volume (10 day Average) 1,465,251
Volume (90 day Average) 2,953,331


Market Capitalization $76.38M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2186Up 0.00 (0.00 %) AS OF 3:59:13PM ET 10/13/2020

Price Performance (Last 52 Weeks)
10/12/2020 +123.06%


Volume 733,108
Volume (10 day Average) 1,495,217
Volume (90 day Average) 2,959,532


Market Capitalization $75.89M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2186Down -0.0101 (-4.416266 %) AS OF 3:50:42PM ET 10/12/2020

Price Performance (Last 52 Weeks)
10/09/2020 +98.87%


Volume 578,288
Volume (10 day Average) 1,526,344
Volume (90 day Average) 2,973,963


Market Capitalization $79.40M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2287Up 0.0072 (3.250564 %) AS OF 3:58:07PM ET 10/09/2020

Price Performance (Last 52 Weeks)
10/08/2020 +88.51%


Volume 1,025,799
Volume (10 day Average) 1,622,399
Volume (90 day Average) 2,973,373


Market Capitalization $76.90M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2215Down -0.0072 (-3.148229 %) AS OF 3:59:02PM ET 10/08/2020

Price Performance (Last 52 Weeks)
10/07/2020 +107.91%

Volume 1,179,666
Volume (10 day Average) 1,616,390
Volume (90 day Average) 2,968,901


Market Capitalization $79.40M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2287Down -0.0082 (-3.461376 %) AS OF 3:59:08PM ET 10/07/2020

Price Performance (Last 52 Weeks)
10/06/2020 +116.74%


Volume 1,055,749
Volume (10 day Average) 1,650,513
Volume (90 day Average) 2,971,532


Market Capitalization $82.25M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.2369Up 0.0069 (3.00 %) AS OF 3:59:48PM ET 10/06/2020

Price Performance (Last 52 Weeks)
10/05/2020 +110.43%


Volume 1,208,894
Volume (10 day Average) 1,651,181
Volume (90 day Average) 2,974,791


Market Capitalization $79.85M
Shares Outstanding 347,186,000
===========================

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.23Up 0.01 (4.545455 %) AS OF 3:59:34PM ET 10/05/2020

Price Performance (Last 52 Weeks)
10/02/2020 +96.43%


Volume 1,468,476
Volume (10 day Average) 1,581,720
Volume (90 day Average) 2,976,062


Market Capitalization $76.38M
Shares Outstanding 347,186,000
===========================

Historical Short Volume Data for IPIX

 
Date Close High Low Volume Sht Vol % of Vol Shtd

Oct 16 NA NA NA 833,773 404,599 48.53%
Oct 15 NA NA NA 425,401 146,077 34.34%
Oct 14 NA NA NA 613,853 234,971 38.28%
Oct 13 NA NA NA 737,108 350,044 47.49%
Oct 12 NA NA NA 578,288 234,444 40.54%
Oct 09 NA NA NA 1,025,799 709,519 69.17%
Oct 08 NA NA NA 1,174,666 760,322 64.73%
Oct 07 NA NA NA 1,055,749 688,727 65.24%
Oct 06 NA NA NA 1,208,894 657,712 54.41%
Oct 05 NA NA NA 1,468,476 977,793 66.59%
Oct 02 NA NA NA 6,245,126 3,662,097 58.64%% *****
Oct 01 NA NA NA 663,935 247,471 37.27%

Sep 30 NA NA NA 475,784 313,022 65.79%
Sep 29 NA NA NA 1,046,776 482,802 46.12%
Sep 28 NA NA NA 889,558 424,164 47.68%
Sep 25 NA NA NA 1,986,343 760,038 38.26%
Sep 24 NA NA NA 1,119,577 253,095 22.61%
Sep 23 NA NA NA 1,396,982 710,712 50.87%
Sep 22 NA NA NA 1,215,571 595,465 48.99%
Sep 21 NA NA NA 773,866 299,446 38.69%
Sep 18 NA NA NA 1,031,043 447,658 43.42%
Sep 17 NA NA NA 1,078,135 663,697 61.56%
Sep 16 NA NA NA 2,788,722 1,268,722 45.49%

Sep 15 NA NA NA 12,948,414 5,507,122 42.53% ****
Sep 14 NA NA NA 568,409 299,316 52.66%
Sep 11 NA NA NA 572,086 344,622 60.24%
Sep 10 NA NA NA 472,282 269,628 57.09%
Sep 09 NA NA NA 436,695 320,996 73.51%
Sep 08 NA NA NA 1,694,578 1,010,478 59.63% ***
Sep 04 NA NA NA 1,619,804 1,072,314 66.20%
Sep 03 NA NA NA 1,467,420 940,998 64.13%
Sep 02 NA NA NA 1,256,071 716,978 57.08%
Sep 01 NA NA NA 933,410 471,778 50.54%

Aug 31 NA NA NA 1,032,019 570,486 55.28%
Aug 28 NA NA NA 913,239 455,111 49.83%
Aug 27 NA NA NA 913,446 574,129 62.85%
Aug 26 NA NA NA 1,601,531 1,059,780 66.17% **
Aug 25 NA NA NA 1,398,358 759,317 54.30%
Aug 24 NA NA NA 6,015,802 3,187,537 52.99% *
Aug 21 NA NA NA 1,312,168 661,297 50.40%
Aug 20 NA NA NA 1,111,127 621,873 55.97%
Aug 19 NA NA NA 1,201,893 581,350 48.37%
Aug 18 NA NA NA 1,397,414 882,970 63.19%
Aug 17 NA NA NA 1,128,186 568,549 50.39%

Aug 14 NA NA NA 1,423,346 692,153 48.63%
Aug 13 NA NA NA 1,057,579 548,523 51.87%
Aug 12 NA NA NA 1,406,491 681,043 48.42%
Aug 11 NA NA NA 1,659,920 850,348 51.23%
Aug 10 NA NA NA 2,015,792 793,871 39.38%
Aug 07 NA NA NA 1,686,981 795,055 47.13%
Aug 06 NA NA NA 2,479,779 1,198,690 48.34%
Aug 05 NA NA NA 1,092,323 504,530 46.19%
Aug 04 NA NA NA 2,625,758 1,630,279 62.09%
Aug 03 NA NA NA 3,611,854 2,507,917 69.44%

Jul 31 NA NA NA 1,035,908 527,927 50.96%
Jul 30 NA NA NA 4,421,368 2,765,370 62.55%
Jul 29 NA NA NA 1,584,578 865,553 54.62%
Jul 28 NA NA NA 1,478,641 947,848 64.10%
Jul 27 NA NA NA 5,429,584 2,982,599 54.93%
Jul 24 NA NA NA 2,804,276 1,635,949 58.34%
Jul 23 NA NA NA 1,443,141 852,554 59.08%
Jul 22 NA NA NA 1,583,764 877,353 55.40%
Jul 21 NA NA NA 2,471,827 1,406,938 56.92%
Jul 20 NA NA NA 7,011,994 3,903,198 55.66%
Jul 17 NA NA NA 1,700,006 948,578 55.80%
Jul 16 NA NA NA 1,572,843 950,607 60.44%

Jul 15 NA NA NA 3,122,082 1,883,905 60.34%
Jul 14 NA NA NA 6,521,081 2,175,892 33.37%
Jul 13 NA NA NA 8,151,877 4,078,491 50.03%
Jul 10 NA NA NA 2,154,827 932,019 43.25%
Jul 09 NA NA NA 1,892,612 1,107,610 58.52%
Jul 08 NA NA NA 2,573,759 1,462,374 56.82%
Jul 07 NA NA NA 4,061,212 2,594,248 63.88%
Jul 06 NA NA NA 2,287,553 1,226,968 53.64%
Jul 02 NA NA NA 3,788,429 1,822,707 48.11%
Jul 01 NA NA NA 1,521,940 646,991 42.51%

Jun 30 NA NA NA 1,742,511 982,243 56.37%
Jun 29 NA NA NA 2,815,051 1,614,501 57.35%
Jun 26 NA NA NA 3,288,168 1,755,618 53.39%
Jun 25 NA NA NA 2,908,354 1,679,709 57.75%
Jun 24 NA NA NA 7,625,067 4,299,436 56.39%
Jun 23 NA NA NA 12,750,039 6,169,402 48.39%
Jun 22 NA NA NA 7,884,928 3,996,456 50.68%
Jun 19 NA NA NA 15,326,213 9,254,306 60.38%



*****Innovation Pharmaceuticals Announces Pre-IND Meeting Request Granted by FDA for the Study of Brilacidin for the Treatment of COVID-19
GLOBENEWSWIRE – 10:00 AM ET 10/02/2020

****Laboratory Testing of Brilacidin for COVID-19 in Combination with Remdesivir Reduces Viral Load by Nearly 100 Percent
GLOBENEWSWIRE – 9:00 AM ET 09/15/2020

***Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports
GLOBENEWSWIRE – 10:00 AM ET 09/08/2020

**Dr. William F. DeGrado, a Discoverer of Brilacidin, Joins Innovation Pharmaceuticals as Scientific Advisor
GLOBENEWSWIRE – 9:30 AM ET 08/26/2020

*COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index Among the Highest Reported, Exhibiting Potent Anti-SARS-CoV-2 Activity at Low Concentrations; Clinical Trial Forthcoming
GLOBENEWSWIRE – 8:00 AM ET 08/24/2020

Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
GLOBENEWSWIRE – 8:00 AM ET 08/04/2020

Innovation Pharmaceuticals Grants Licensing Rights to Fox Chase Chemical Diversity Center, Inc. for Antifungal Technology
GLOBENEWSWIRE – 8:00 AM ET 07/22/2020

Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 07/20/2020

Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
GLOBENEWSWIRE – 8:00 AM ET 07/13/2020

In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial
GLOBENEWSWIRE – 8:00 AM ET 07/07/2020

Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
GLOBENEWSWIRE – 7:30 AM ET 06/17/2020


IPIX YTD *Volume* as of EO SEO 2020 ~ 524,227,725

IPIX *Volume* by month as *reported* to Finra 2020

 
SEP 2020 ~ 35,785,026 ** matches 2/2020
AUG 2020 ~ 37,279,662
JUL 2020 ~ 68,767,947
JUN 2020 ~ 116,020,124 *** highest in 2020
MAY 2020 ~ 51,886,542
APR 2020 ~ 78,324,274
MAR 2020 ~ 86,903,508
FEB 2020 ~ 35,015,032 ** matches 10/2020
JAN 2020 ~ 14,245,610 * lowest in 2020


as a reminder IPIX's YTD Volume in 2018 was 88M~
as a reminder NR (non retail) injected *volume* of approx 55M~ in last 4 mos of 2018 (PPS reset from 53c to 7c)
as a reminder iPIX's YTD Volume in 2019 was 124M~
as a reminder NR injected *volume* in May 2019 of approx 23M~ to negate AS
as a reminder IPIX's YTD Volume @ EO October 2019 was 94M~
as a reminder IPIX's YTD Volume @ EO September 2020 was 524M~

https://otce.finra.org/otce/marketStatistics/...hareVolume

NR is between a rock and a hard space re: IPIX (stock)

https://investorshangout.com/post/view?id=5703011

as always best to all Innovation Pharma investors ..

4kids












1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 6

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
New Podcast by Paralyzed Veterans of America Offers Unique Insights

Updated Category News Views 3

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 5

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Subaru, Motorq Offer Hardware-Free Fleet Telematics Insights

Updated Category News Views 3

An Unplugged Move in Fleet Management There's something brewing between Motorq and Subaru that could shake up fleet operations in ways most haven't thought possible yet. We’re talking about cutting those pesky hardware cords and diving straight into a future that's software-driven—and hey, we're all here for it. Direct, Data-Driven Leadership Imagine you're a fleet...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 5

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Sequel Advisors Rebrand: Founder-Centric M&A Focus

Updated Category News Views 5

What's in a Name? A Shift to Reflect Reality When a company decides it's time to shake things up with a rebrand, they better have a good reason. Enter what's now called Sequel Advisors—shedding the old label, Transact Capital, to let founders know exactly what they’re dealing with upfront. This isn't just some slick, new logo on a letterhead. It's about aligning their...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 6

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 3

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
CATL Opens Europe's Largest Battery Service Hub

Updated Category News Views 2

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Continue Reading

Top 5 Most Recently Viewed Articles

Dycom Industries to Engage Investors at Upcoming Conference

Updated Category News Views 149

Dycom Industries, Inc. to Engage Investors at Conference Dycom Industries, Inc. (NYSE: DY) is gearing up for an exciting opportunity to engage with investors at the KeyBanc Industrial & Basic Materials Conference. This prestigious event will be held in Boston, where Dycom's senior management team will host various one-on-one and group meetings with attendees. The...

Continue Reading
MIFTI Launches Early Adopter Program for Energy Revolution

Updated Category News Views 597

Introduction to MIFTI's Innovative Energy Solutions MIFTI (Magneto Inertial Fusion Technologies, Inc.) ushers in a new chapter in energy production with its groundbreaking Early Adopter Program. This initiative opens doors for forward-thinking organizations to pre-order access to energy generated by MIFTI's Small Modular Reactors (SMR) employing Staged Z-Pinch Fusion...

Continue Reading
Protection for Investors: Designer Brands Class Action Insights

Updated Category News Views 157

Understanding the Class Action Investigation for Designer Brands Inc. Designer Brands Inc. (NYSE: DBI) is facing scrutiny as the Rosen Law Firm, a respected global law firm dedicated to investor rights, is actively investigating potential securities claims arising from recent allegations against the company. These allegations suggest that Designer Brands may have issued...

Continue Reading
Pet King Brands and ZYMOX Support Adoption Initiative

Updated Category News Views 173

Pet King Brands and ZYMOX's Role in Supporting Pet Adoption Pet King Brands, a well-recognized name in the pet care industry, has always been committed to enhancing the health of pets through innovative products. This year, they are proudly supporting the 17th Annual "Get Your Licks on Route 66® Pet Adoption Tour," aimed at helping pets find loving homes nationwide....

Continue Reading
Duke Energy's Winter Preparation and Energy Efficiency Tips

Updated Category News Views 312

Duke Energy's Winter Preparations Duke Energy is actively monitoring weather forecasts and taking necessary steps to brace for an impending winter storm. This storm, characterized by a combination of snow, sleet, and freezing rain, poses a risk of power outages in various regions. With the cold weather approaching, it is vital for customers to prepare accordingly....

Continue Reading